The DOI matches its Crossref record; 165 of the 165 references it cites were found in a registry or an index.
Selective leptin resistance revisited
Open accessAbstract
In addition to effects on appetite and metabolism, leptin influences many neuroendocrine and physiological systems, including the sympathetic nervous system. Building on my Carl Ludwig Lecture of the American Physiological Society, I review the sympathetic and cardiovascular actions of leptin. The review focuses on a critical analysis of the concept of selective leptin resistance (SLR) and the role of leptin in the pathogenesis of obesity-induced hypertension in both experimental animals and humans. We introduced the concept of SLR in 2002 to explain how leptin might increase blood pressure (BP) in obese states, such as diet-induced obesity (DIO), that are accompanied by partial leptin resistance. This concept, analogous to selective insulin resistance in the metabolic syndrome, holds that in several genetic and acquired models of obesity, there is preservation of the renal sympathetic and pressor actions of leptin despite attenuation of the appetite and weight-reducing actions. Two potential overlapping mechanisms of SLR are reviewed: 1) differential leptin molecular signaling pathways that mediate selective as opposed to universal leptin action and 2) brain site-specific leptin action and resistance. Although the phenomenon of SLR in DIO has so far focused on preservation of sympathetic and BP actions of leptin, consideration should be given to the possibility that this concept may extend to preservation of other actions of leptin. Finally, I review perplexing data on the effects of leptin on sympathetic activity and BP in humans and its role in human obesity-induced hypertension.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Leptin infusions in rodents over several days also cause mild, gradual increases in BP and HR125–127.”
From Obesity, kidney dysfunction and hypertension: mechanistic links (2019) · cites this paper as [126]
In the citing paper
“Although the suppressive effects of leptin on food intake are blunted in obesity, its acute stimulatory actions on RSNA seem to be preserved, suggesting selective leptin resistance126,136.”
From Obesity, kidney dysfunction and hypertension: mechanistic links (2019) · cites this paper as [126]
In the citing paper
“Leptin receptors (LepR) are expressed in many areas of the brain, including the ventromedial hypothalamus, arcuate nucleus (ARC) and dorsomedial areas of the hypothalamus, as well as in vasomotor centers of the brainstem and spinal cord intermediolateral nucleus (IML)93.”
From Obesity-Induced Hypertension: Interaction of Neurohumoral and Renal Mechanisms (2015) · cites this paper as [93]
In the citing paper
“Leptin is less effective in suppressing appetite in obese compared to lean experimental animals93.”
From Obesity-Induced Hypertension: Interaction of Neurohumoral and Renal Mechanisms (2015) · cites this paper as [93]
In the citing paper
“A large body of evidence has demonstrated that leptin contributes to sympathetic overactivity and hypertension in a number of animal models of monogenic and diet-induced obesity74–77.”
From The Sympathetic Nervous System Alterations in Human Hypertension (2015) · cites this paper as [77]
In the citing paper
“There are, however, data from several studies in relatively large numbers of lean and obese subjects that have failed to show an increase in blood pressure with chronic or acute administration of leptin77.”
From The Sympathetic Nervous System Alterations in Human Hypertension (2015) · cites this paper as [77]
In the citing paper
“Surprisingly then, evidence that leptin contributes to obesity-associated hypertension in humans is inconclusive77.”
From The Sympathetic Nervous System Alterations in Human Hypertension (2015) · cites this paper as [77]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Warne, J. P., Alemi, F., Reed, A. S., Varonin, J. M., Chan, H., Piper, M., Mullin, M. E., Myers, M. G., Corvera, C., & Xu, A. W. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.11.001 · Cited by 43
RetractedPositional cloning of the mouse obese gene and its human homologue
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Banting lecture 1988. Role of insulin resistance in human disease.
Reaven, G. (1988) · Diabetes · doi:10.2337/diabetes.37.12.1595 · Cited by 3,801
Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus
Cowley, M. A., Smart, J. L., Rubinstein, M., Cerdán, M. G., Diano, S., Horvath, T. L., Cone, R. D., & Low, M. J. (2001) · Nature · doi:10.1038/35078085 · Cited by 2,356
A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction
Clément, K., Vaisse, C., Lahlou, N., Cabrol, S., Pelloux, V., Cassuto, D., Gourmelen, M., Dina, C., Chambaz, J., Lacorte, J.-M., et al. (1998) · Nature · doi:10.1038/32911 · Cited by 2,346
Abnormal splicing of the leptin receptor in diabetic mice
Lee, G.-H., Proenca, R., Montez, J. M., Carroll, K. M., Darvishzadeh, J. G., Lee, J. I., & Friedman, J. M. (1996) · Nature · doi:10.1038/379632a0 · Cited by 2,327
Effects of Recombinant Leptin Therapy in a Child with Congenital Leptin Deficiency
Farooqi, I. S., Jebb, S. A., Langmack, G., Lawrence, E., Cheetham, C. H., Prentice, A. M., Hughes, I. A., McCamish, M. A., & O'Rahilly, S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909163411204 · Cited by 1,998
Heymsfield, S. B., Greenberg, A. S., Fujioka, K., Dixon, R. M., Kushner, R., Hunt, T., Lubina, J. A., Patane, J., Self, B., Hunt, P., et al. (1999) · JAMA · doi:10.1001/jama.282.16.1568 · Cited by 1,422
Leptin regulation of bone resorption by the sympathetic nervous system and CART
Elefteriou, F., Ahn, J. D., Takeda, S., Starbuck, M., Yang, X., Liu, X., Kondo, H., Richards, W. G., Bannon, T. W., Noda, M., et al. (2005) · Nature · doi:10.1038/nature03398 · Cited by 1,311 · cited 1×
“The surprising finding was that leptin also increased SNA to the kidney, adrenal gland, and hindlimb, (29, 58, 78, 88), and it has subsequently been shown to regulate sympathetic activity to liver (153), bone (31), and the splanchnic circulation (75).”
Research works printed but not linked: 3
- Landsberg L, 1986, Q J Med, 61, 1081
- Rosmond R, 2000, J Clin Endocrinol Metab, 85, 3126
- Tanida M, 2003, In Vivo, 17, 213
Cited by
Sorted by citations
Obesity-Induced Hypertension: Interaction of Neurohumoral and Renal Mechanisms
Hall, J. E., do Carmo, J. M., da Silva, A. A., Wang, Z., & Hall, M. E. (2015) · Circulation Research · doi:10.1161/circresaha.116.305697 · Cited by 1,360
Leptin and Obesity: Role and clinical implication.
Obradovic, M., Sudar-Milovanovic, E., Soskic, S., Essack, M., Arya, S., Stewart, A. J., Gojobori, T., & Isenovic, E. R. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.585887 · Cited by 1,121
Obesity, Adipose Tissue and Vascular Dysfunction
Koenen, M., Hill, M. A., Cohen, P., & Sowers, J. R. (2021) · Circulation Research · doi:10.1161/circresaha.121.318093 · Cited by 979
Seravalle, G., & Grassi, G. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.05.013 · Cited by 909
Leptin and the endocrine control of energy balance
Friedman, J. M. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0095-y · Cited by 661
Metadata
- Authors
- Mark, A. L.
- Affiliations
- University of Iowa (US)
- Corresponding author
- Mark, Allyn L.
- ORCID
- Mark, Allyn L.
- Venue
- American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Publisher
- American Physiological Society
- Published
- 2013-09-15
- Volume
- 305
- Issue
- 6
- Pages
- R566-R581
- ISSN
- 0363-6119 (ISSN-L)
- 1522-1490
- PMC
- PMC3763044
- OpenAlex
- W2064109637
- Cited by
- 162
- References
- 165
- Citations by year
- 2026: 7 · 2025: 4 · 2024: 12 · 2023: 6 · 2022: 6 · 2021: 16 · 2020: 13 · 2019: 12 · 2018: 11 · 2017: 14 · 2016: 17 · 2015: 19 · 2014: 22 · 2013: 3
- FWCI
- 2.45
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- American Journal of Physiology-Regulatory, Integrative and Comparative Physiology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5p50hl044546-05)
- National Heart, Lung, and Blood Institute (HL-55006, HL-96571, R01HL063887, HL-63887, HL-14388, HL-84207, HL-44546, P50HL055006, P01HL014388, P01HL084207, P01HL096571)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Keywords
- leptin, obesity-related hypertension, diet-induced obesity, sympathetic nervous system, blood pressure regulation, leptin signaling, appetite regulation
- MeSH terms
- Animals, Brain, Humans, Hypertension, Myocardium, Obesity, Sympathetic Nervous System, Leptin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
